HopeLab, a non-profit company out of Palo Alto, CA, has just announced the release of Re-Mission™, “the first videogame scientifically shown to improve health-related outcomes for young people with cancer, an underserved and overlooked population who are at greater risk for adverse cancer outcomes.”
This biologicaly accurate, at the cellular level, shooter is designed with qn oncological pediatric patient in mind. Here’s what the press release says:
The study is the first-ever randomized, controlled trial focused exclusively on adolescents and young adults with cancer. Data from the study showed statistically significant improvements in cancer-related self-efficacy, social quality of life, cancer-specific
knowledge, and adherence to prescribed medication regimens in patients who played Re-Mission.
Re-Mission was developed through the collaborative efforts of young people with cancer, researchers, medical experts and game developers. The game combines biologic accuracy with an honest depiction of the challenges faced by young cancer patients. Re-Mission’s main character, Roxxi, is a gutsy, fully-armed Nanobot who seeks out and
destroys cancer cells throughout the human body, battling cancer and its life-threatening effects. Through 20 different levels of game play, Re-Mission illustrates what occurs inside the bodies of young cancer patients and how they can most effectively fight their
The game is PC-based and rated “T” (for Teen). It was recently covered (.pdf) in Wired.
The press release (.pdf)… More materials for clinicians….
Free download for patients is available here…
(hat tip: New Launches)